Irma M. Grossi

1.7k total citations
26 papers, 1.3k citations indexed

About

Irma M. Grossi is a scholar working on Molecular Biology, Hematology and Immunology and Allergy. According to data from OpenAlex, Irma M. Grossi has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Hematology and 11 papers in Immunology and Allergy. Recurrent topics in Irma M. Grossi's work include Cell Adhesion Molecules Research (11 papers), Platelet Disorders and Treatments (9 papers) and Inflammatory mediators and NSAID effects (6 papers). Irma M. Grossi is often cited by papers focused on Cell Adhesion Molecules Research (11 papers), Platelet Disorders and Treatments (9 papers) and Inflammatory mediators and NSAID effects (6 papers). Irma M. Grossi collaborates with scholars based in United States and Germany. Irma M. Grossi's co-authors include Clement A. Diglio, Kenneth V. Honn, L A Fitzgerald, K. V. Honn, Dean G. Tang, John D. Taylor, József Tı́már, Yong Q. Chen, Kevin Nelson and John D. Taylor and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Journal of Virology.

In The Last Decade

Irma M. Grossi

26 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irma M. Grossi United States 20 598 368 278 260 257 26 1.3k
Hollis R. Williams United States 12 337 0.6× 140 0.4× 55 0.2× 36 0.1× 179 0.7× 15 810
Shama Kajiji United States 14 372 0.6× 382 1.0× 65 0.2× 33 0.1× 75 0.3× 23 1.1k
P A Marks United States 20 1.0k 1.7× 28 0.1× 164 0.6× 44 0.2× 113 0.4× 36 1.5k
H Neda Japan 18 756 1.3× 72 0.2× 44 0.2× 24 0.1× 163 0.6× 45 1.3k
Kylie A. Hotchkiss United States 12 622 1.0× 63 0.2× 75 0.3× 22 0.1× 169 0.7× 13 1.0k
Z. Mishal France 19 487 0.8× 41 0.1× 101 0.4× 26 0.1× 102 0.4× 32 922
Boris Tchernychev United States 17 365 0.6× 238 0.6× 253 0.9× 22 0.1× 141 0.5× 24 1.0k
SHOJI KISHIMOTO Japan 11 798 1.3× 117 0.3× 57 0.2× 99 0.4× 388 1.5× 24 1.3k
Shigeru Ushiyama Japan 11 328 0.5× 380 1.0× 89 0.3× 76 0.3× 140 0.5× 33 757
Jessica Hauschild Germany 17 565 0.9× 95 0.3× 22 0.1× 128 0.5× 186 0.7× 34 1.1k

Countries citing papers authored by Irma M. Grossi

Since Specialization
Citations

This map shows the geographic impact of Irma M. Grossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irma M. Grossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irma M. Grossi more than expected).

Fields of papers citing papers by Irma M. Grossi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irma M. Grossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irma M. Grossi. The network helps show where Irma M. Grossi may publish in the future.

Co-authorship network of co-authors of Irma M. Grossi

This figure shows the co-authorship network connecting the top 25 collaborators of Irma M. Grossi. A scholar is included among the top collaborators of Irma M. Grossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irma M. Grossi. Irma M. Grossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hutson, Christina L., Ashley V. Kondas, Matthew R. Mauldin, et al.. (2021). Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model. mSphere. 6(1). 135 indexed citations
2.
Grossi, Irma M., et al.. (2017). Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand White rabbits. Antiviral Research. 143. 278–286. 34 indexed citations
3.
4.
Mao, Li, Hui Wang, Donald L. Hill, et al.. (2005). Preclinical pharmacology of the novel antitumor agent adaphostin, a tyrphostin analog that inhibits bcr/abl. Cancer Chemotherapy and Pharmacology. 57(5). 607–614. 10 indexed citations
5.
Parise, Robert A., et al.. (2004). Liquid chromatography-electrospray tandem mass spectrometric assay suitable for quantitation of halofuginone in plasma. Journal of Chromatography B. 810(1). 35–40. 6 indexed citations
6.
Tang, Dean G., et al.. (1995). Inhibition of TPA and 12(S)‐HETE‐stimulated tumor cell adhesion by prostacyclin and its stable analogs: Rationale for their antimetastatic effects. International Journal of Cancer. 60(3). 418–425. 15 indexed citations
7.
Honn, Kenneth V., Dean G. Tang, Irma M. Grossi, et al.. (1994). Enhanced Endothelial Cell Retraction Mediated by 12(S)-HETE: A Proposed Mechanism for the Role of Platelets in Tumor Cell Metastasis. Experimental Cell Research. 210(1). 1–9. 56 indexed citations
8.
9.
Steinert, Bruce W., et al.. (1993). Studies on the role of platelet eicosanoid metabolism and integrin αIIbβ3 in tumor‐cell‐induced platelet aggregation. International Journal of Cancer. 54(1). 92–101. 39 indexed citations
10.
Tang, Dean G., Irma M. Grossi, Yong Q. Chen, Clement A. Diglio, & Kenneth V. Honn. (1993). 12(S)‐hete promotes tumor‐cell adhesion by increasing surface expression of αVβ3 integrins on endothelial cells. International Journal of Cancer. 54(1). 102–111. 59 indexed citations
11.
Chen, Yong Q., József Tı́már, Irma M. Grossi, et al.. (1992). Increased expression of αIIb β3 integrin in subpopulations of murine melanoma cells with high lung‐colonizing ability. International Journal of Cancer. 51(3). 445–451. 43 indexed citations
12.
Chopra, Hemi, József Tı́már, Irma M. Grossi, et al.. (1992). Is there a role for the tumor cell integrin ?IIb?3 and cytoskeleton in tumor cell-platelet interaction?. Clinical & Experimental Metastasis. 10(2). 125–137. 30 indexed citations
13.
Honn, Kenneth V., Yong Q. Chen, József Tı́már, et al.. (1992). αIIbβ3 Integrin expression and function in subpopulations of murine tumors. Experimental Cell Research. 201(1). 23–32. 41 indexed citations
14.
Chen, Yong Q., Xiang Gao, József Tı́már, et al.. (1992). Identification of the alpha IIb beta 3 integrin in murine tumor cells.. Journal of Biological Chemistry. 267(24). 17314–17320. 55 indexed citations
15.
Chopra, Hemi, József Tı́már, Yong Q. Chen, et al.. (1991). The lipoxygenase metabolite 12(S)‐hete induces a cytoskeleton‐dependent increase in surface expression of integrin αiibβ3 on melanoma cells. International Journal of Cancer. 49(5). 774–786. 81 indexed citations
16.
Grossi, Irma M., et al.. (1989). Bidirectional control of membrane expression and/or activation of the tumor cell IRGpIIb/IIIa receptor and tumor cell adhesion by lipoxygenase products of arachidonic acid and linoleic acid.. PubMed. 49(4). 1029–37. 139 indexed citations
17.
Honn, K. V., et al.. (1988). Lipoxygenase Products Regulate IRGpllb/llla Receptor Mediated Adhesion of Tumor Cells to Endothelial Cells, Subendothelial Matrix and Fibronectin. Experimental Biology and Medicine. 189(1). 130–135. 37 indexed citations
18.
Chopra, Hemi, James S. Hatfield, Irma M. Grossi, et al.. (1988). Role of tumor cytoskeleton and membrane glycoprotein IRGpIIb/IIIa in platelet adhesion to tumor cell membrane and tumor cell-induced platelet aggregation.. PubMed. 48(13). 3787–800. 46 indexed citations
19.
Onoda, James M., et al.. (1988). Separation of High and Low Metastatic Subpopulations from Solid Tumors by Centrifugal Elutriation. Experimental Biology and Medicine. 187(2). 250–255. 20 indexed citations
20.
Grossi, Irma M., L A Fitzgerald, A. G. Kendall, et al.. (1987). Inhibition of Human Tumor Cell Induced Platelet Aggregation by Antibodies to Platelet Glycoproteins lb and llb/llla. Experimental Biology and Medicine. 186(3). 378–383. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hollis R. Williams Breakdown of academic impact, for papers by Shama Kajiji Breakdown of academic impact, for papers by P A Marks Breakdown of academic impact, for papers by H Neda Breakdown of academic impact, for papers by Kylie A. Hotchkiss Breakdown of academic impact, for papers by Z. Mishal Breakdown of academic impact, for papers by Boris Tchernychev Breakdown of academic impact, for papers by SHOJI KISHIMOTO Breakdown of academic impact, for papers by Shigeru Ushiyama Breakdown of academic impact, for papers by Jessica Hauschild
Rankless by CCL
2026